Proton MR Spectroscopy in the Diagnostic Evaluation of Suspected Mitochondrial Disease

References

1. ↵
   DiMauro S, Moraes CT. Mitochondrial encephalomyopathies. Arch Neurol 1993;50:1197–1208

   CrossRefPubMedWeb of Science
2. Hanna MG, Nelson IP. Genetics and molecular pathogenesis of mitochondrial respiratory chain diseases. Cell Mol Life Sci 1999;55:691–706

   CrossRefPubMedWeb of Science
3. ↵
   Simon DK, Johns DR. Mitochondrial disorders: clinical and genetic features. Annu Rev Med 1999;50:111–127

   CrossRefPubMedWeb of Science
4. ↵
   Nissenkorn A, Zeharia A, Lev D, et al. Multiple presentation of mitochondrial disorders. Arch Dis Child 1999;81:209–214

   Abstract/FREE Full Text
5. ↵
   Munoz A, Mateos F, Simon R, Garcia Silva MT, Cabello S, Arenas J. Mitochondrial diseases in children: neuroradiological and clinical features in 17 patients. Neuroradiology 1999;41:920–928

   CrossRefPubMedWeb of Science
6. ↵
   Nissenkorn A, Zeharia A, Lev D, et al. Neurologic presentations of mitochondrial disorders. J Child Neurol 2000;15:44–48

   Abstract/FREE Full Text
7. ↵
   Johns DR. Seminars in medicine of the Beth Israel Hospital, Boston: mitochondrial DNA and disease. N Engl J Med 1995;333:638–644

   CrossRefPubMedWeb of Science
8. ↵
   Barkovich AJ, Good WV, Koch TK, Berg BO. Mitochondrial disorders: analysis of their clinical and imaging characteristics. AJNR Am J Neuroradiol 1993;14:1119–1137

   Abstract/FREE Full Text
9. van der Knaap MS, Jakobs C, Valk J. Magnetic resonance imaging in lactic acidosis. J Inherit Metab Dis 1996;19:535–547

   CrossRefPubMedWeb of Science
10. ↵
    Valanne L, Ketonen L, Majander A, Suomalainen A, Pihko H. Neuroradiologic findings in children with mitochondrial disorders. AJNR Am J Neuroradiol 1998;19:369–377

    Abstract
11. ↵
    Argov Z. Functional evaluation techniques in mitochondrial disorders. Eur Neurol 1998;39:65–71

    CrossRefPubMedWeb of Science
12. ↵
    Castillo M, Kwock L, Green C. MELAS syndrome: imaging and proton MR spectroscopic findings. AJNR Am J Neuroradiol 1995;16:233–239

    Abstract/FREE Full Text
13. Pavlakis SG, Kingsley PB, Kaplan GP, Stacpoole PW, O’Shea M, Lustbader D. Magnetic resonance spectroscopy: use in monitoring MELAS treatment. Arch Neurol 1998;55:849–852

    CrossRefPubMedWeb of Science
14. ↵
    Wilichowski E, Pouwels PJ, Frahm J, Hanefeld F. Quantitative proton magnetic resonance spectroscopy of cerebral metabolic disturbances in patients with MELAS. Neuropediatrics 1999;30:256–263

    PubMedWeb of Science
15. ↵
    Matthews PM, Andermann F, Silver K, Karpati G, Arnold DL. Proton MR spectroscopic characterization of differences in regional brain metabolic abnormalities in mitochondrial encephalomyopathies. Neurology 1993;43:2484–2490

    Abstract/FREE Full Text
16. ↵
    Barker PB, Soher BJ, Blackband SJ, Chatham JC, Mathews VP, Bryan RN. Quantitation of proton NMR spectra of the human brain using tissue water as an internal concentration reference. NMR Biomed 1993;6:89–94

    CrossRefPubMedWeb of Science
17. ↵
    Duyn JH, Gillen J, Sobering G, van Zijl PC, Moonen CT. Multisection proton MR spectroscopic imaging of the brain. Radiology 1993;188:277–282

    PubMedWeb of Science
18. ↵
    Evans OB, Parker CC, Haas RH, Naidu S, Moser HW, Block H-GO. Inborn errors of metabolism of the nervous system. In: Bradley WG, Daroff RB, Fenichel GM, Marsden CD, eds. Neurology in Clinical Practice: The Neurological Disorders. 3rd ed. Woburn: Butterworth-Heinemann;2000 :1595–1664
19. ↵
    Servidei S. Mitochondrial encephalomyopathies: gene mutation. Neuromuscul Disord 2002;12:524–529

    CrossRefPubMed
20. ↵
    Horska A, Kaufmann WE, Brant LJ, Naidu S, Harris JC, Barker PB. In vivo quantitative proton MRSI study of brain development from childhood to adolescence. J Magn Reson Imaging 2002;15:137–143

    CrossRefPubMedWeb of Science
21. ↵
    Bowen J, Richards T, Maravilla K. MR imaging and proton MR spectroscopy in A-to-G substitution at nucleotide position 3243 of leucine transfer RNA. AJNR Am J Neuroradiol 1998;19:231–234

    Abstract
22. ↵
    Dubeau F, De Stefano N, Zifkin BG, Arnold DL, Shoubridge EA. Oxidative phosphorylation defect in the brains of carriers of the tRNAleu(UUR) A3243G mutation in a MELAS pedigree. Ann Neurol 2000;47:179–185

    CrossRefPubMedWeb of Science
23. ↵
    Cross JH, Gadian DG, Connelly A, Leonard JV. Proton magnetic resonance spectroscopy studies in lactic acidosis and mitochondrial disorders. J Inherit Metab Dis 1993;16:800–811

    CrossRefPubMed
24. ↵
    De Stefano N, Matthews PM, Arnold DL. Reversible decreases in N-acetylaspartate after acute brain injury. Magn Reson Med 1995;34:721–727

    PubMedWeb of Science
25. ↵
    Shungu DC, Sano M, Millar WS, et al. Metabolic, structural, and neuropsychological deficits in mitochondrial encephalopathies assessed by ¹H MRSI, MRI, and neuropsychological testing. Presented at the International Society for Magnetic Resonance in Medicine Conference, Philadelphia, May 22–28,1999
26. ↵
    Inao S, Marmarou A, Clarke GD, Andersen BJ, Fatouros PP, Young HF. Production and clearance of lactate from brain tissue, cerebrospinal fluid, and serum following experimental brain injury. J Neurosurg 1988;69:736–744

    PubMedWeb of Science